Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110872 · ClinicalTrials.gov registry record · NA
Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
NCT05110872: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT05110872 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 302 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05110872, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
Study Summary
This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.
Primary Outcome
Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price. Product availability in the ETM depended on the experimental condition. The average percentage of budget spent on e-cigarettes as a function of the restriction of cigarettes and/or e-cigarettes will be assessed.
Interventions
- BEHAVIORAL Cigarette flavor restricted and e-cigarette flavor restricted
- BEHAVIORAL Cigarette flavor restricted and e-cigarette flavor unrestricted
- BEHAVIORAL Cigarette flavor unrestricted and e-cigarette flavor restricted
- BEHAVIORAL Cigarette flavor unrestricted and e-cigarette flavor unrestricted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2021-08-13 |
| Phase | NA |
What the finished NCT05110872 record still lists
NCT05110872 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 4 interventions - of which Cigarette flavor restricted and e-cigarette flavor restricted is the first listed.
NCT05110872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05110872 about?
NCT05110872 is a clinical study titled "Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace". This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.
What is the current status of trial NCT05110872?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2021-07-26. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT05110872?
The interventions under investigation include: Cigarette flavor restricted and e-cigarette flavor restricted (BEHAVIORAL), Cigarette flavor restricted and e-cigarette flavor unrestricted (BEHAVIORAL), Cigarette flavor unrestricted and e-cigarette flavor restricted (BEHAVIORAL), Cigarette flavor unrestricted and e-cigarette flavor unrestricted (BEHAVIORAL).
Who is sponsoring clinical trial NCT05110872?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05110872's enrollment target sits among peer trials
302 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI